Glatect is believed to work by modifying the immune processes involved in multiple sclerosis (MS).
Understanding Glatect's Mechanism
Glatect's precise mechanism of action in treating Multiple Sclerosis (MS) is not fully understood, but it is thought to function by modulating the immune system. Specifically, it aims to alter the immune responses that are believed to be responsible for causing the damage seen in MS.
-
Modulating Immune Processes: The primary action of Glatect is to influence and change the immune system's behavior. In MS, the immune system mistakenly attacks the myelin sheath, the protective covering of nerve fibers in the brain and spinal cord. Glatect aims to reduce this self-attack.
-
Targeting the Root Cause of MS: By modifying the immune processes, Glatect targets what is believed to be the underlying cause of MS, rather than just treating the symptoms.
While the precise details of how Glatect achieves this modulation are still under investigation, the current understanding points to a role in shifting the balance of immune responses away from those that damage myelin and towards those that are more protective.
